ArticleCurrent microbiology2025
Wheat-associated Antagonistic Bacteria Exerts Biocontrol Activity Against Fungal Growth and Deoxynivalenol Production in Fusarium Graminearum.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fusarium head blight (FHB), primarily caused by Fusarium graminearum, leads to severe contamination of wheat grains with the mycotoxin deoxynivalenol (DON), posing a significant threat to grain safety and quality. While chemical control remains common, its efficacy is increasingly challenged by fungicide resistance and potential stimulation of DON production. Biological control represents a promising alternative, yet the identification of effective antagonistic agents and elucidation of their mechanisms are still needed. This study evaluated the biocontrol potential of the endophytic bacterium Bacillus velezensis strain 6W1 against FHB and DON contamination. The crude antagonistic extract exhibited a clear dose-dependent inhibitory effect on the mycelial growth of F. graminearum. The EC₅₀ value was determined to be 210.79 µg/mL, and complete growth inhibition (100%) was achieved when the extract concentration reached 800 µg/mL. Likewise, DON biosynthesis was significantly suppressed in a concentration-dependent manner, with DON levels reduced to 0 at 800 µg/mL of the crude extract.Furthermore, macrolactin A was identified as the core antagonistic compound responsible for the observed antifungal activity. A field trial confirmed that strain 6W1 application significantly reduced FHB severity and DON accumulation in wheat grains. These findings demonstrate the potential of B. velezensis 6W1 as an effective biocontrol agent against FHB and provide a theoretical basis for its application in managing DON contamination.
Indexed as
Identifiers
41441895What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.